King Fahad Medical City - BioBank Department, Saudi Arabia

Registration Status: Pending

Objective: 1. Through dedication, learning, growth, modern technology and knowledge, King Fahad Medical City Biobank will retain the biological material and clinical data safely and securely to be used in translational studies and targeted therapy that impact health outcomes. It will focus mainly on the most common ten solid cancers, most of leukemia and lymohoma in Saudi Arabia. Due to high frequency of many metabolic syndromes, they will be part of our focus 2. Contribute toward healthy citizens by sharing information and biological material and data with other healthcare and research facilities. This include many governmental institutes that are not under the umbrella of Ministry of Health 3. To be a center of excellence for training and education in Biobank at Ministry of Health Level.

Registered Biobank Name King Fahad Medical City - BioBank Department
Biobank Leader Mosa Fagih
Country Saudi Arabia
Email for biobank inquiries mfageeh@KFMC.med.sa
Principal Investigator Mosa Ali Fagih
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.
Biospecimen Collected: